Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.

MLA

Yan, Ting-Ting, et al. “Downregulation of RPL15 May Predict Poor Survival and Associate with Tumor Progression in Pancreatic Ductal Adenocarcinoma.” Oncotarget, vol. 6, no. 35, Nov. 2015, pp. 37028–42. EBSCOhost, https://doi.org/10.18632/oncotarget.5939.

APA

Yan, T.-T., Fu, X.-L., Li, J., Bian, Y.-N., Liu, D. J., Hua, R., Ren, L.-L., Li, C.-T., Sun, Y.-W., Chen, H.-Y., Fang, J.-Y., & Hong, J. (2015). Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma. Oncotarget, 6(35), 37028–37042. https://doi.org/10.18632/oncotarget.5939

Chicago

Yan, Ting-Ting, Xue-Liang Fu, Jiao Li, Ying-Nan Bian, D Jun Liu, Rong Hua, Lin-Lin Ren, et al. 2015. “Downregulation of RPL15 May Predict Poor Survival and Associate with Tumor Progression in Pancreatic Ductal Adenocarcinoma.” Oncotarget 6 (35): 37028–42. doi:10.18632/oncotarget.5939.